Green Cures Botanical Stock Price To Earnings To Growth
GRCU Stock | USD 0.0002 0.0001 100.00% |
Green Cures Botanical fundamentals help investors to digest information that contributes to Green Cures' financial success or failures. It also enables traders to predict the movement of Green Pink Sheet. The fundamental analysis module provides a way to measure Green Cures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Green Cures pink sheet.
Green |
Green Cures Botanical Company Price To Earnings To Growth Analysis
Green Cures' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Green Cures Botanical has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
All Next | Launch Module |
Green Fundamentals
Return On Equity | 0.55 | |||
Return On Asset | 0.023 | |||
Profit Margin | 4.96 % | |||
Operating Margin | 0.62 % | |||
Current Valuation | 4.85 M | |||
Price To Sales | 2.80 X | |||
Revenue | 13.17 K | |||
Gross Profit | 989.6 K | |||
EBITDA | 861.7 K | |||
Net Income | (1.09 M) | |||
Cash And Equivalents | 80 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 3.1 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.85 X | |||
Book Value Per Share | (2.23) X | |||
Cash Flow From Operations | (73.09 K) | |||
Earnings Per Share | 3.15 X | |||
Number Of Employees | 20 | |||
Beta | 1.09 | |||
Market Capitalization | 2.54 M | |||
Total Asset | 406 | |||
Retained Earnings | (1.58 M) | |||
Working Capital | (539 K) | |||
Current Liabilities | 539 K | |||
Z Score | -22.03 | |||
Net Asset | 406 |
About Green Cures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Green Cures Botanical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cures Botanical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.